The National Emergency Strategic Stockpile (NESS) is a federally owned and managed stockpile of emergency supplies, including influenza antivirals.The NAS is intended to provide antivirals for all eligible persons living in Canada including federal populations within a jurisdiction, such as on reserve First Nations and correctional facility inmates. The National Antiviral Stockpile (NAS) is the collective name for the antiviral stockpiles held and managed by each PT.In Canada, there are two government stockpiles of antivirals intended for pandemic influenza use: Since 2004, Canadian FPT governments have been stockpiling antivirals to help ensure pan-Canadian equitable access to a secure, government-controlled supply of antivirals to be used during a pandemic. They are the only influenza-specific intervention that can be used to mitigate the impact of an influenza pandemic before vaccine becomes available. 1.0 Introduction 1.1 BackgroundĪntiviral medications (known as antivirals) are used to treat persons with influenza or given to persons, either pre or post exposure, to prevent influenza. While CPIP is specific to pandemic influenza, much of its guidance is also applicable to other public health emergencies, such as outbreaks of other communicable diseases. Rather, it is a guidance document for pandemic influenza that can be used to support an FPT public health emergency response approach. It is important to note that CPIP is not an actual response plan. While it is anticipated that CPIP's strategic direction and guidance will inform FPT planning to support a consistent and coordinated response across jurisdictions, provinces and territories (PT) have ultimate responsibility for planning and decision-making within their respective jurisdictions. CPIP's main body and annexes are intended to be used together. The Antiviral Annex of the Canadian Pandemic Influenza Preparedness: Planning Guidance for the Health Sector (CPIP) is a federal, provincial and territorial (FPT) guidance document that outlines how jurisdictions will work together to ensure a coordinated and consistent health-sector approach to Canada's antiviral strategy. 2.1 Planning Scenarios and NAS optimization.2.0 Background on Antiviral Stockpile Optimization using Pandemic Planning Scenarios and Modeling Data.Appendix C- Expert recommendations for the national antiviral stockpile.Appendix B - Example of clinical guidance on antiviral use.

Institute of Medicine (IOM)'s Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic Goals and Values from the Antiviral Deliberative Dialogue Process University of Alberta Survey on Allocation of Scarce Resources during an Influenza Pandemic Canadian Program of Research Ethics in a Pandemic (CanPREP) Projects

Appendix A2 - Public consultations regarding prioritization.

Appendix A1 - Information needs for antiviral prioritization decision-making.

4.0 Process for Developing Recommendations.

3.3.1 Antiviral Strategies and Potential Target Groups.

3.1.1 Disease Characteristics and Burden (Pandemic Epidemiology).

3.0 Considerations for Antiviral Prioritization.

Appendix A - Antiviral Prioritization Framework.

4.0 Integration with Other Response Components.

3.7 Triggers for Action and Key Decisions and Activities.

3.6.2 Risk Management Considerations for the Antiviral Strategy.

3.5.7 Monitoring Antiviral Utilization, Resistance and Effectiveness.

3.5.3 Clinical Recommendations for Antiviral Use.

3.4 Pandemic Roles and Responsibilities.

2.4 Program Delivery in the Canadian Context.

2.3 Lessons Learned from the 2009 Pandemic.2.1 Role of Antivirals in Prevention and Treatment of Pandemic Influenza.

Define stockpile pills